Evidence map›Paper›PMID 26401224›Full record

ArticleThe Pan African medical journal2015

Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.

Heather Melissa Scobie, Benoît Kebela Ilunga, Audry Mulumba, Calixte Shidi, Tiekoura Coulibaly, Ricardo Obama, Jean-Jacques Muyembe Tamfum, Elisabeth Pukuta Simbu, Sheilagh Brigitte Smit, Balcha Masresha and 4 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Measles: The Re-emergence of a Vaccine-Preventable Disease.Infectious diseases & clinical microbiology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Detection of human parvovirus B19 in serum samples from children under 5 years of age with rash-fever illnesses in the Democratic Republic of the Congo.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Heather Melissa ScobieCenters for Disease Control and Prevention, Atlanta, Georgia, USA ; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta.
Benoît Kebela IlungaMinistry of Public Health, Kinshasa, Democratic Republic of the Congo.
Audry MulumbaMinistry of Public Health, Kinshasa, Democratic Republic of the Congo.
Calixte ShidiMinistry of Public Health, Kinshasa, Democratic Republic of the Congo.
Tiekoura CoulibalyWorld Health Organization, Kinshasa.
Ricardo ObamaWorld Health Organization, Kinshasa.
Jean-Jacques Muyembe TamfumNational Institute for Biomedical Research, Kinshasa.
Elisabeth Pukuta SimbuNational Institute for Biomedical Research, Kinshasa.
Sheilagh Brigitte SmitNational Institute for Communicable Diseases, Johannesburg, South Africa.
Balcha MasreshaWorld Health Organization African Regional Office, Brazzaville, Republic of the Congo.
Robert Tyrrell PerryWorld Health Organization, Geneva, Switzerland.
Mary Margaret AllemanCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Katrina KretsingerCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
James GoodsonCenters for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionDespite accelerated measles control efforts, a massive measles resurgence occurred in the Democratic Republic of the Congo (DRC) starting in mid-2010, prompting an investigation into likely causes.

methodsWe conducted a descriptive epidemiological analysis using measles immunization and surveillance data to understand the causes of the measles resurgence and to develop recommendations for elimination efforts in DRC.

resultsDuring 2004-2012, performance indicator targets for case-based surveillance and routine measles vaccination were not met. Estimated coverage with the routine first dose of measles-containing vaccine (MCV1) increased from 57% to 73%. Phased supplementary immunization activities (SIAs) were conducted starting in 2002, in some cases with sub-optimal coverage (≤95%). In 2010, SIAs in five of 11 provinces were not implemented as planned, resulting in a prolonged interval between SIAs, and a missed birth cohort in one province. During July 1, 2010-December 30, 2012, high measles attack rates (>100 cases per 100,000 population) occurred in provinces that had estimated MCV1 coverage lower than the national estimate and did not implement planned 2010 SIAs. The majority of confirmed case-patients were aged <10 years (87%) and unvaccinated or with unknown vaccination status (75%). Surveillance detected two genotype B3 and one genotype B2 measles virus strains that were previously identified in the region.

conclusionThe resurgence was likely caused by an accumulation of unvaccinated, measles-susceptible children due to low MCV1 coverage and suboptimal SIA implementation. To achieve the regional goal of measles elimination by 2020, efforts are needed in DRC to improve case-based surveillance and increase two-dose measles vaccination coverage through routine services and SIAs.

Indexed as

Disease OutbreaksAdolescentChildChild, PreschoolDemocratic Republic of the CongoGenotypeHumansImmunizationInfantMeaslesMeasles VaccineMeasles virusPopulation SurveillanceMeasles VaccineDRCeliminationimmunizationMeaslesoutbreakRDCsurveillancevaccination

Identifiers

PMID26401224
PMCPMC4561157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.